海洋链霉菌次级代谢产物研究进展

doi:10.19586/j.2095-2341.2023.0093

生物技术进展 ›› 2023, Vol. 13 ›› Issue (6): 844-852.DOI: 10.19586/j.2095-2341.2023.0093

• 进展评述 • 上一篇

海洋链霉菌次级代谢产物研究进展

陈巧莉¹^,²^,³(), 黄杰¹^,²^,³, 陈森瑜¹^,²^,³, 潘少婷¹^,²^,³, 唐灵芝¹^,²^,³, 洪璇¹^,²^,³()

^1.厦门医学院，厦门市海洋药用天然产物资源重点实验室，福建厦门 361023
^2.厦门医学院，海洋生物医药资源福建省高校工程研究中心，福建厦门 361023
^3.厦门医学院药学系，福建厦门 361023

收稿日期:2023-07-28 接受日期:2023-08-29 出版日期:2023-11-25 发布日期:2023-12-12
通讯作者: 洪璇
作者简介:陈巧莉E-mail: c202005450082@outlook.com；
基金资助:
国家级大学生创新创业训练计划项目(202312631001);福建省自然科学基金面上项目(2022J011401);厦门市自然科学基金面上项目(3502Z20227227);福建省大学生创新创业训练计划项目(S202212631006);福建省本科高校教育教学改革研究项目(FBJG20190201);厦门医学院校级科研项目(K2023-25)

Research Progress on Secondary Metabolites of Marine Streptomyces

Qiaoli CHEN¹^,²^,³(), Jie HUANG¹^,²^,³, Senyu CHEN¹^,²^,³, Shaoting PAN¹^,²^,³, Lingzhi TANG¹^,²^,³, Xuan HONG¹^,²^,³()

^1.Xiamen Key Laboratory of Marine Medicinal Natural Products Resources，Xiamen Medical College，Fujian Xiamen 361023，China
^2.Fujian Universities and Colleges Engineering Research Center of Marine Biopharmaceutical Resources，Xiamen Medical College，Fujian Xiamen 361023，China
^3.School of Pharmacy and Pharmaceutical Sciences，Xiamen Medical College，Fujian Xiamen 361023，China

Received:2023-07-28 Accepted:2023-08-29 Online:2023-11-25 Published:2023-12-12
Contact: Xuan HONG

摘要/Abstract

摘要：

链霉菌作为最高等的放线菌，广泛分布于多种生态环境中，具有复杂而独特的形态分化周期和强大的次级代谢能力。链霉菌的次级代谢产物具有抗感染、抗肿瘤、抗炎抗氧化、免疫调节等生物活性，是天然活性产物的主要来源之一。近年来随着对海洋资源的开发，许多新型的海洋链霉菌及其丰富的次级代谢产物被发现。从海洋链霉菌的生物活性物质、育种和发酵培养3个方面综述了海洋链霉菌次级代谢产物的研究进展，以期为缩短海洋链霉菌的发酵周期，提高次级代谢产物产量活性以及开发新型的海洋药物等提供参考和借鉴。

关键词: 海洋链霉菌, 次级代谢产物, 生物活性

Abstract:

Streptomyces is widely distributed in various ecological environments as the most advanced actinomycete. It has complex and unique morphological differentiation cycles and strong secondary metabolic abilities. Secondary metabolites of Streptomyces have many biological activities such as anti-infection， anti-tumor， anti-inflammatory and anti-oxidant， immune adjustment and other biological activities， which is one of the main sources of natural active products. In recent years， with the development of marine resources， many new types of marine Streptomyces and their rich secondary metabolites have been discovered. The research on secondary metabolites of marine Streptomyces was reviewed， and the bioactive substances， breeding and fermentation culture of marine Streptomyces were summarized， in order to provide reference and help in shortening the fermentation cycle of marine Streptomyces，improving the yield and activity of secondary metabolites， and developing new marine drugs.

Key words: marine Streptomyces, secondary metabolites, biological activity

中图分类号:

Q935

陈巧莉, 黄杰, 陈森瑜, 潘少婷, 唐灵芝, 洪璇. 海洋链霉菌次级代谢产物研究进展[J]. 生物技术进展, 2023, 13(6): 844-852.

Qiaoli CHEN, Jie HUANG, Senyu CHEN, Shaoting PAN, Lingzhi TANG, Xuan HONG. Research Progress on Secondary Metabolites of Marine Streptomyces[J]. Current Biotechnology, 2023, 13(6): 844-852.

图/表 1

参考文献 48

1	薛正莲,王珊,孙俊峰,等.链霉菌形态分化与次级代谢产物合成的研究进展[J].微生物学报,2021,61(12):3870-3886.
2	王聪,梅显贵,朱伟明.海洋链霉菌来源的天然产物[J].海洋科学集刊,2016(1):86-124.
3	郎晓萌,林文翰,季宇彬.海洋链霉菌生物活性物质的研究[J].哈尔滨商业大学学报(自然科学版),2010,26(2):136-141.
4	李慧玲,赵玉瑛,姚敏娜,等.海洋链霉菌Streptomyces sp. S598中抗菌活性产物的研究[J].中国抗生素杂志,2020,45(6):560-566.
5	CHO E, KWON O S, CHUNG B, et al.. Antibacterial activity of chromomycins from a marine-derived Streptomyces microflavus [J/OL]. Mar. Drugs, 2020, 18(10): 522[2023-10-20]. .
6	CARLSON J C, LI S, BURR D A, et al.. Isolation and characterization of tirandamycins from a marine-derived Streptomyces sp.[J]. J. Nat. Prod., 2009, 72(11): 2076-2079.
7	ELSILK S E, KHALIL M A, ABOSHADY T A, et al.. Streptomyces rochei MS-37 as a novel marine actinobacterium for green biosynthesis of silver nanoparticles and their biomedical applications[J/OL]. Molecules, 2022, 27(21): 7296[2023-10-23]. .
8	ELSILK S E, KHALIL M A, ABOSHADY T A, et al.. Streptomyces rochei MS-37 as a novel marine actinobacterium for green biosynthesis of silver nanoparticles and their biomedical applications[J/OL]. Molecules, 2022, 27(21): 7296[2023-10-20]. .
9	LIN H Y, LIN Y S, SHIH S P, et al.. The anti-proliferative activity of secondary metabolite from the marine Streptomyces sp. against prostate cancer cells[J/OL]. Life, 2021, 11(12): 1414[2023-10-20]. .
10	古静燕.海洋白浅灰链霉菌Streptomyces albogriseolus A2002抗肿瘤活性成分的研究[D].青岛:中国海洋大学,2004.
11	赖珍珠.两株链霉菌次级代谢产物研究[D].广州:广州医科大学, 2017.
12	FAHMY N M, ABDEL-TAWAB A M. Isolation and characterization of marine sponge-associated Streptomyces sp. NMF6 strain producing secondary metabolite(s) possessing antimicrobial, antioxidant, anticancer, and antiviral activities[J/OL]. J. Genet. Eng. Biotechnol., 2021, 19(1): 102[2023-10-20]. .
13	WIBOWO J T, KELLERMANN M Y, KÖCK M, et al.. Anti-infective and antiviral activity of valinomycin and its analogues from a sea cucumber-associated bacterium, Streptomyces sp. SV 21[J/OL]. Mar. Drugs, 2021, 19(2): 81[2023-10-20]. .
14	HOU L, WANG S, HUANG H, et al.. Generation of methylated violapyrones with improved anti-influenza A virus activity by heterologous expression of a type Ⅲ PKS gene in a marine Streptomyces strain[J]. Bioorg. Med. Chem. Lett., 2018, 28(17): 2865-2868.
15	赵韵宇,孙伟,彭崇胜,等.海洋放线菌Streptomyces variabilis strain 6-1次级代谢产物的研究[J].现代生物医学进展,2012, 12(26):5001-5004.
16	LIU D, YAN R, FU Y, et al.. Antifungal, growth-promotingplant, and genomic properties of an endophytic actinobacterium Streptomyces sp. NEAU-S7GS2[J/OL]. Front. Microbiol., 2019, 10: 2077[2023-10-20]. .
17	麻金金,葛蓓孛,施李鸣,等.玫瑰黄链霉菌NKZ-259发酵培养基的优化[J].生物技术通报, 2019,35(2):85-92.
18	RAMESH C, ANWESH M, VINITHKUMAR N V, et al.. Complete genome analysis of undecylprodigiosin pigment biosynthesizing marine Streptomyces species displaying potential bioactive applications[J/OL]. Microorganisms, 2021, 9(11): 2249[2023-10-20]. .
19	CHEN W, YE K, ZHU X, et al.. Actinomycin X2, an antimicrobial depsipeptide from marine-derived Streptomyces cyaneofuscatus applied as a good natural dye for silk fabric[J/OL]. Mar. Drugs, 2021, 20(1): 16[2023-10-20]. .
20	DHARMARAJ S, ASHOKKUMAR B, DHEVENDARAN K. Food-grade pigments from Streptomyces sp. isolated from the marine sponge Callyspongia diffusa [J]. Food Res. Int., 2009, 42(4): 487-492.
21	SHEEFAA M I, SIVAPERUMAL P. Antioxidant activities from melanin pigment produced by marine actinobacterium of Streptomyces species[J]. J. Adv. Pharm. Technol. Res., 2022, 13(S1): 84-87.
22	VERMA P, CHATTERJEE S, KEZIAH M S, et al.. Fibrinolytic protease from marine Streptomyces rubiginosus VITPSS1[J]. Cardiovasc. Hematol. Agents Med. Chem., 2018, 16(1): 44-55.
23	ZHANG H, DONG S, LOU T, et al.. Complete genome sequence unveiled cellulose degradation enzymes and secondary metabolic potentials in Streptomyces sp. CC0208[J]. J. Basic Microbiol., 2019, 59(3): 267-276.
24	陈瑞勤,廖丽,张晓华,等.北极海洋链霉菌604F的卤化酶基因克隆及特征[J].微生物学报,2014,54(6):703-712.
25	CHEN H, LIN B, ZHANG R, et al.. Controllable preparation of chitosan oligosaccharides via a recombinant chitosanase from marine Streptomyces lydicus S1 and its potential application on preservation of pre-packaged tofu[J/OL]. Front. Microbiol., 2022, 13: 1007201[2023-10-20]. .
26	江宏磊,王传喜,江宁宇,等.海洋来源链霉菌FIM090041产生的神经氨酸酶抑制剂[J].中国抗生素杂志,2012,37(4):265-268+275.
27	CHEN Z, HAO J, WANG L, et al.. New α-glucosidase inhibitors from marine algae-derived Streptomyces sp. OUCMDZ-3434[J/OL]. Sci. Rep., 2016, 6: 20004[2023-10-20]. .
28	GUO Y, YAO J, SUN C, et al.. Characterization of the deep-sea Streptomyces sp. SCSIO 02999 derived VapC/VapB toxin-antitoxin system in Escherichia coli [J/OL]. Toxins, 2016, 8(7): 195[2023-10-20]. .
29	杨闰英,胡志浩,邓子新,等.苏云金芽孢杆菌δ-内毒素cryIA(c)基因在大肠杆菌和变铅青链霉菌中表达[J].生物工程学报, 1998,14(2):119-124.
30	郑红芸,吴越叶景静,等.三株红树林来源链霉菌的鉴定及抗菌活性研究[J].中国药理学通报,2019,35(7):985-990.
31	盖翠娟,董姣姣,杨爱岗,等. 生物与化学方法相结合提高海洋生境放线菌YB-24菌株星形孢菌素产量[J].中国抗生素杂志,2015,40(5):325-329.
32	李鹏,王健鑫,罗红宇,等.一株产淀粉酶海洋放线菌菌株的选育及发酵条件的研究[J].水产学报,2014,38(12):2059-2067.
33	侯孝仑,刘雅清,郭玮婷,等.原生质体融合提高产谷氨酰胺转氨酶菌株产量[J].食品科学,2016,37(3):145-150.
34	孟国庆,陆震,赵林,等.Genome shuffling育种技术应用研究进展[J].山东轻工业学院学报(自然科学版),2010,24(2):6-11.
35	陈瑞琦.天蓝色链霉菌气生菌丝相关蛋白SCO4184的功能研究[D].天津: 天津大学, 2020.
36	杨海花,田宇清,贾君永,等.天蓝色链霉菌分化调控基因scrX的功能研究[J].中国科学(C辑),2000(2):153-162.
37	刘象博.土壤微生物及海洋链霉菌次级代谢产物生物合成基因的挖掘[D].南京:南京农业大学,2018.
38	JIANG L, WANG L, ZHANG J, et al.. Identification of novel mureidomycin analogues via rational activation of a cryptic gene cluster in Streptomyces roseosporus NRRL15998[J/OL]. Sci. Rep., 2015, 5: 14111[2023-10-20]. .
39	HOSHUNO S, ONAKA H, ABE I. Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria[J]. J. Ind. Microbiol. Biotechnol., 2019, 46(3-4): 363-374.
40	黄忠瑶.海洋链霉菌遗传转化系统及次级代谢产物的基因筛选 [D].南京:南京农业大学,2014.
41	TIAN X P, XU Y, ZHANG J, et al.. Streptomyces oceani sp. nov., a new obligate marine actinomycete isolated from a deep-sea sample of seep authigenic carbonate nodule in South China Sea [J]. Antonie Van Leeuwenhoek, 2012, 102(2): 335-343.
42	张大杉.基于不同发酵方式的三株海洋微生物活性次级代谢产物研究[D].杭州:浙江大学,2019.
43	薛一达,丛丽娜,李若凡.海洋链霉菌HS-B31发酵条件优化及活性物质分离纯化[J].大连工业大学学报,2020,39(4):245-249.
44	王高学,段星,原居林,等.一株抗多种水产病原菌放线菌的鉴定、发酵优化及其应用[J].上海水产大学学报,2008,17(5):591-597.
45	刘倩倩,吴远杰,张正玉,等.子囊霉素生产菌种的选育及发酵优化[J].中国医药工业杂志,2022,53(6):842-848.
46	卢文玉,闻建平,范晶华,等.癸酸抗性突变株流加发酵法生产达托霉素[J].天津大学学报,2006,39(S1):20-24.
47	项仁鑫,杨小虎,方佳双,等.响应面法优化链霉菌HY6-S36产星孢菌素的发酵条件[J].中国抗生素杂志,2021,46(8):749-755.
48	徐涤,李富超, LAATSCH,等.培养条件对链霉菌Streptomyces次级代谢产物的影响[Z].中国第六届海洋湖沼药物学术开发研讨会论文集,浙江宁波,2000:195-197.

[1]	鲍佳生, 潘丙珍, 乔栖梧, 刘慧智, 潘素华. 酵母生物活性物质及其化妆品功效研究进展[J]. 生物技术进展, 2023, 13(3): 345-352.
[2]	宋开南, 谢李楠, 徐玉泉. 真菌除草活性次级代谢产物研究进展[J]. 生物技术进展, 2023, 13(2): 181-194.
[3]	徐萍,陈瑶,李倩,张伟杰,于萍,胡琴汉,赵婷,茆广华,冯伟伟,仰榴青. 虫蛹活性多肽的制备、分离和生物活性研究进展[J]. 生物技术进展, 2018, 8(5): 383-388.
[4]	于萍,李倩,王未,郑大恒,张伟杰,赵婷,张敏,茆广华,冯伟伟,仰榴青. 灰树花多糖的分子修饰及其活性研究进展[J]. 生物技术进展, 2018, 8(1): 21-27.
[5]	常白杨,汪建明,王敏,王彤彤. 烟曲霉素及其衍生物生物活性研究进展[J]. 生物技术进展, 2017, 7(6): 580-586.
[6]	孙姗姗,高亚辉,陈俊德. 胶原蛋白肽金属螯合物及其生产制备工艺的研究进展[J]. 生物技术进展, 2017, 7(4): 290-295.
[7]	李玲玲. 青蒿内生真菌研究进展[J]. 生物技术进展, 2016, 6(3): 185-187.
[8]	李梦瀛,闫培生,高秀君,孙晓磊. 深海真菌多样性及其代谢产物生物活性的研究进展[J]. 生物技术进展, 2015, 5(3): 170-175.
[9]	王全富,苗苗,侯艳华,史永磊,韩涵,吴莹莹,严天奇,曲俊杰. 硫氧还蛋白研究进展[J]. 生物技术进展, 2015, 5(3): 196-200.
[10]	吴泽,魏琦峰,邱庆庆,任秀莲. 褐藻多糖的分离提取及生理活性研究进展[J]. 生物技术进展, 2015, 5(3): 201-206.
[11]	林丽莎,张珅,詹岳霖,王增焜,林河通 ,. 仙草的化学成分和药理作用研究进展[J]. 生物技术进展, 2013, 3(6): 448-52.
[12]	洪钦阳,肖水华,邹情雅,刘红,关雄. 苏云金芽胞杆菌生物活性成分研究进展[J]. 生物技术进展, 2013, 3(2): 85-89.
[13]	杨阳,张付云,苍桂璐,王斌,卢航. 地衣芽胞杆菌生物活性物质应用研究进展[J]. 生物技术进展, 2013, 3(1): 22-26.
[14]	伍水龙,江黎明. 红树林放线菌研究进展[J]. 生物技术进展, 2012, 2(5): 335-340.
[15]	信艳娟,艾江宁,刘亚男,吴佩春,曹旭鹏,薛松. 一株海洋放线菌的分离鉴定及活性研究[J]. 生物技术进展, 2012, 2(5): 354-358.

海洋链霉菌次级代谢产物研究进展

Research Progress on Secondary Metabolites of Marine Streptomyces

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 48

相关文章 15

编辑推荐

Metrics

本文评价